
Eugene C. Tarne
Senior AnalystEugene C. Tarne is a senior analyst with the Charlotte Lozier Institute. He is also the president of Tarne Communications Inc., a communications and issue advocacy company he founded in 1999. For more than 25 years, beginning in 1989, Mr. Tarne served as a communications and media relations consultant to the United States Conference of Catholic Bishops Secretariat for Pro-Life Activities. In this capacity, he works closely with the Pro-Life Secretariat to develop messages, promote issues and legislation, develop new programs and materials and implement communications strategies designed to educate the public and promote pro-life issues in the public square. These issues include abortion, assisted suicide and euthanasia, and bioethical issues, especially cloning and stem cell research. In 1996, Mr. Tarne helped found the Physicians Ad Hoc Coalition for Truth (PHACT), an organization of doctors and other medical professionals formed to bring the medical facts to bear on the partial-birth abortion debate. Mr. Tarne also served as Communications Director for Do No Harm: The Coalition of Americans for Research Ethics, a coalition of scientists, researchers, bioethicists, medical, academic and other professionals, patient advocates, and concerned individuals, established in 1999, to promote the ethical pursuit of stem cell research and regenerative medicine in general, and to provide accurate information on such research. Mr. Tarne graduated from Georgetown University in 1977 with a B.A. in Theology. He received his M.A. in History of Religions from The George Washington University in 1979. He was offered scholarships to Harvard, the University of Chicago and the University of Pennsylvania to pursue a Ph.D. in South Asian Studies. He attended the University of Chicago and later the University of Pennsylvania, where he completed his Ph.D. studies, except for dissertation.
Research Authored
Cloning is Cloning is Cloning
This primer on cloning examines the nature and purpose of human cloning in light of recent developments in stem cell technology. The paper points out that all cloning is reproductive and reflects on the immediate outcome of human cloning - a human
Maryland Joins the Trend for Ethical Stem Cell Research
This paper continues the investigation of stem cell research funding in the United States by examining the funding patterns at the Maryland Stem Cell Research Commission. This investigation reveals that the Maryland Commission is keeping with the trend of investing more money
Ideas Have Consequences
The horrors revealed at the trial of Philadelphia abortionist Kermit Gosnell have put abortion advocates in a defensive pose. Among the charges Gosnell faces are murder in the death of a woman undergoing an abortion, murder in the deaths of four newborns, and
New California Grants Once Again Bolster Ethical Stem Cell Alternatives
The most recent round of grants by the California Institute for Regenerative Medicine (CIRM) demonstrates – again – where the future of stem cell research lies. As documented in a previous publication on this website, since its first round of grants to
Justice Not Sought for Unborn Victims of Violence
A recent pretrial hearing of Fort Hood shooter Major Nidal Hasan provides the opportunity to again raise the question as to why prosecutors are not seeking justice for all the victims of the 2009 massacre. At the hearing, attorneys for Hasan
Major Step Forward for Ethical Stem Cell Research
A major New England biotech company recently announced that it would begin the process that it hopes will result in the first clinical trial using induced pluripotent stem cells (iPSCs). This is hardly surprising, as the discovery, by Shinya Yamanaka, of the process
The Ethical Stems of Good Science
This paper examines the funding pattern of the California Institute for Regenerative Medicine, an institution which characterizes itself as the “largest source of funding for stem cell research outside the NIH.” Tarne demonstrates that funding has moved from grants directed primarily towards
Possible Adult Stem Cell Therapy for Blood-Disorders in Down Syndrome
A recent study from researchers at the University of Washington announced a major step forward in the treatment of genetic diseases and specifically in treating Down syndrome patients. Down syndrome occurs when there is an extra copy of chromosome 21 (hence its alternative
Dr. Yamanaka’s Nobel Prize a Victory for Ethical Stem Cell Research
The Nobel Prize for Medicine awarded to Japan’s Shinya Yamanaka last month is a thoroughly deserved recognition of his groundbreaking work in regenerative medicine, work that just five years ago forever changed the way stem cell research is conducted around the globe.